Pathological fracture following minimal trauma as the initial presentation of parathyroid carcinoma–associated hyperparathyroidism in a young man: a case report - Scorecard - MDSpire

Pathological fracture following minimal trauma as the initial presentation of parathyroid carcinoma–associated hyperparathyroidism in a young man: a case report

  • By

  • Miljanka Vuksanović

  • Bojan Kovačević

  • Jelena Kuzmanović

  • Vladimir Vasić

  • Ognjen Krčmar

  • Milica Marjanović Petković

  • May 8, 2026

  • 0 min

Share

Clinical Scorecard: Initial Presentation of Parathyroid Carcinoma-Related Hyperparathyroidism in a Young Male: A Case of Pathological Fracture After Minimal Trauma

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationYoung adults, particularly males, typically presenting after age 40.
Care Setting

Key Highlights

  • Add: Imaging studies are crucial for accurate diagnosis of parathyroid carcinoma.

Guideline-Based Recommendations

Diagnosis

  • Consider ultrasound or sestamibi scans for identifying parathyroid tumors.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Specify the type of bisphosphonates used for hypercalcemia management.

        Clinical Best Practices

        • Include management strategies for severe arterial hypertension in patients with hyperparathyroidism.

        References

        Original Source(s)

        Pathological fracture following minimal trauma as the initial presentation of parathyroid carcinoma–associated hyperparathyroidism in a young man: a case report

        • by Miljanka Vuksanović, Bojan Kovačević, Jelena Kuzmanović, Vladimir Vasić, Ognjen Krčmar, Milica Marjanović Petković

        • May 8, 2026

        Related Content

        Approach to the Pediatric Patient With Glucocorticoid-Induced Osteoporosis

        Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism

        Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality